Hello and welcome to the EpiPen® website
02 June 2020
Availability of EpiPen® 0.15mg and 0.3mg
Adrenaline Auto-Injectors
Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen®, had previously experienced manufacturing challenges which resulted in interruptions in the supply of EpiPen Jr 0.15mg and EpiPen 0.3mg Adrenaline Auto-Injectors (AAIs).
Supply has stabilised further and there is good availability of both EpiPen Jr 0.15mg and EpiPen 0.3mg AAIs. The prescription validation process previously applied is no longer in place and stock can be ordered as normal.
-
Information for Prescribers
The prescription validation previously in place no longer applies and stock can be ordered as normal.
Prescribers are reminded that Medicines and Health Regulatory Agency (MHRA) guidelines recommend patients carry two adrenaline auto-injectors at all times.
-
Instructions for Pharmacists
Pharmacies are able to place orders and hold stock of EpiPen Jr 0.15mg and EpiPen 0.3mg AAI devices so that patient prescriptions can be fulfilled the same day.
Please place your order through Alliance Healthcare, stating your account number in the request.
-
Instructions for Hospitals
Hospitals are able to place orders and hold stock of EpiPen Jr 0.15mg and EpiPen 0.3mg AAIs.
Please place your order through Alliance Healthcare, stating your account number in the request.
-
Instructions for Schools
To support children and young adults who may be at risk of anaphylaxis whilst away from home, the Human Medicines (Amendment) Regulations 2017 allows schools, without the need for a prescription, to purchase and hold supply of adrenaline auto-injectors. Regulations allow the purchase of a reasonable number of adrenaline auto-injectors for use on an occasional basis and as required.
Orders for EpiPen Jr 0.15mg and EpiPen 0.3mg can be made through your local pharmacy. Please provide your pharmacy with a letter written on your school’s headed paper and signed by the principal or headteacher. The pharmacy will then send the request to Mylan’s distribution partner, Alliance Healthcare.
-
Extended Expiration Dates for Specific Lots of EpiPen® 0.3mg Adrenaline Auto-Injectors
In August 2019, the MHRA granted approval for Mylan UK to permanently extend the shelf life of EpiPen 0.3mg auto-injectors from 20 months to 24 months.
For AAIs already on the market, prior to the permanent extension of shelf life above, Mylan UK obtained approval from the MHRA to extend the use of specific lot (batch) numbers of EpiPen® 0.3mg auto‐injectors, 4 months beyond the labelled expiry date. The affected lot numbers are listed in the table below.
This batch-specific extended use does not apply to EpiPen® 0.15mg AAI or any lot number of EpiPen 0.3 mg auto-injectors not specified. It is important that patients must continue to adhere to the labelled expiry date on any EpiPen® not covered by the lot numbers below.
EpiPen® 0.3mg (single pack)
LOT Original Expiry Date
Extended Expiry Date
8KB332M
02/2020
06/2020
8FA366K
02/2020
06/2020
8FA367B
02/2020
06/2020
8KB478B
04/2020
08/2020
8KB474B
04/2020
08/2020
8KB481B
04/2020
08/2020
8KB510G
05/2020
09/2020
8KB523G
05/2020
09/2020
8KB648B
06/2020
10/2020
8KB587B
06/2020
10/2020
8KB630C
06/2020
10/2020
8KB587F
06/2020
10/2020
8KB671R
07/2020
11/2020
9KB087B
10/2020
02/2021
9KB148B
10/2020
02/2021
9KB177AE
11/2020
03/2021
9KB262B
12/2020
04/2021
EpiPen® 0.3mg (twin pack)
LOT Original Expiry Date
Extended Expiry Date
8KB558C
05/2020
09/2020
8KB630D
06/2020
10/2020
8KB671F
07/2020
11/2020
9KB148J
10/2020
02/2021
9KB177E
11/2020
03/2021
9KB252P
11/2020
03/2021
9KB301J
12/2020
04/2021
-
Further information
You can find the lot number on the end-flap of the box and on the EpiPen® itself. If you’re unsure whether your EpiPen® is affected, talk to your pharmacist.
At the end of the extended use period (the end of the month listed under “Extended Expiry Date” in the table above), you will still need to obtain a new auto-injector by the usual means.
Please note that the information provided in this communication supersedes any other communication that patients receive from the Expiry Alert Service.
-
Contact Information
Telephone: +44 (0)1707 853 000
Medical Information e-mail: info@mylan.co.uk
Please select from one of the following options:
I am a UK
patient
These pages are intended only for patients, parents or carers of those prescribed an EpiPen®.
I am a
member of
the public
Takes you to a website intended for people (not patients) looking to find out more information about Mylan UK.
I am a
UK healthcare
professional
These pages are intended for UK healthcare professionals who would like more information on EpiPen®.
The active ingredient and instructions for use are the same for the EpiPen® and EpiPen® Jr so the information in this website is applicable whether you have been prescribed EpiPen® or EpiPen® Jr and the term EpiPen® used throughout applies to both.
